Successful eradication of inhibitor of late recurrence and other high risk prognostic factors in a patient with severe haemophilia A
Authors:
- 30 May 2011
- journal article
- Published by Wiley in Haemophilia
- Vol. 17 (5) , e833-e834
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Optimizing management of immune tolerance induction in patients with severe haemophilia A and inhibitors: towards evidence‐based approachesBritish Journal of Haematology, 2010
- Assessing risk factors: prevention of inhibitors in haemophiliaHaemophilia, 2010
- Von Willebrand factor-containing factor VIII concentrates and inhibitors in haemophilia AThrombosis and Haemostasis, 2010
- Rituximab and immune tolerance in severe hemophilia A: a consecutive national cohortJournal of Thrombosis and Haemostasis, 2009
- Immune tolerance with rituximab in congenital haemophilia with inhibitors: a systematic literature review based on individual patients’ analysisHaemophilia, 2008
- IgG subclasses of anti‐FVIII antibodies during immune tolerance induction in patients with hemophilia ABritish Journal of Haematology, 2008